236 related articles for article (PubMed ID: 11941539)
21. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
[TBL] [Abstract][Full Text] [Related]
22. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.
Cooney KA; McCarthy JD; Lange E; Huang L; Miesfeldt S; Montie JE; Oesterling JE; Sandler HM; Lange K
J Natl Cancer Inst; 1997 Jul; 89(13):955-9. PubMed ID: 9214675
[TBL] [Abstract][Full Text] [Related]
24. The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men.
Kotar K; Hamel N; Thiffault I; Foulkes WD
J Med Genet; 2003 Mar; 40(3):e22. PubMed ID: 12624151
[No Abstract] [Full Text] [Related]
25. Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.
Larson BT; Magi-Galluzzi C; Casey G; Plummer SJ; Silverman R; Klein EA
J Urol; 2008 Apr; 179(4):1344-8. PubMed ID: 18289577
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
27. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer.
Grönberg H; Smith J; Emanuelsson M; Jonsson BA; Bergh A; Carpten J; Isaacs W; Xu J; Meyers D; Trent J; Damber JE
Am J Hum Genet; 1999 Jul; 65(1):134-40. PubMed ID: 10364525
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
Grönberg H; Isaacs SD; Smith JR; Carpten JD; Bova GS; Freije D; Xu J; Meyers DA; Collins FS; Trent JM; Walsh PC; Isaacs WB
JAMA; 1997 Oct; 278(15):1251-5. PubMed ID: 9333266
[TBL] [Abstract][Full Text] [Related]
30. RNASEL mutations in hereditary prostate cancer.
Chen H; Griffin AR; Wu YQ; Tomsho LP; Zuhlke KA; Lange EM; Gruber SB; Cooney KA
J Med Genet; 2003 Mar; 40(3):e21. PubMed ID: 12624150
[No Abstract] [Full Text] [Related]
31. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.
Berry R; Schaid DJ; Smith JR; French AJ; Schroeder JJ; McDonnell SK; Peterson BJ; Wang ZY; Carpten JD; Roberts SG; Tester DJ; Blute ML; Trent JM; Thibodeau SN
Am J Hum Genet; 2000 Feb; 66(2):539-46. PubMed ID: 10677314
[TBL] [Abstract][Full Text] [Related]
32. Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
Datta A; Mazumder MH; Chowdhury AS; Hasan MA
Biomed Res Int; 2015; 2015():271458. PubMed ID: 26236721
[TBL] [Abstract][Full Text] [Related]
33. RNASEL germline variants are associated with pancreatic cancer.
Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
[TBL] [Abstract][Full Text] [Related]
34. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.
Rennert H; Bercovich D; Hubert A; Abeliovich D; Rozovsky U; Bar-Shira A; Soloviov S; Schreiber L; Matzkin H; Rennert G; Kadouri L; Peretz T; Yaron Y; Orr-Urtreger A
Am J Hum Genet; 2002 Oct; 71(4):981-4. PubMed ID: 12145743
[TBL] [Abstract][Full Text] [Related]
35. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
[TBL] [Abstract][Full Text] [Related]
36. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
37. Association of E-cadherin germ-line alterations with prostate cancer.
Ikonen T; Matikainen M; Mononen N; Hyytinen ER; Helin HJ; Tommola S; Tammela TL; Pukkala E; Schleutker J; Kallioniemi OP; Koivisto PA
Clin Cancer Res; 2001 Nov; 7(11):3465-71. PubMed ID: 11705864
[TBL] [Abstract][Full Text] [Related]
38. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE; Ramos EM; Boulard M; Duda K; Overgaard J; Nordsmark M; Wiuf C; Hansen LL
PLoS One; 2008 Jun; 3(6):e2492. PubMed ID: 18575592
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
40. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
